REMSIMA (IP-APS) subst sèche 100 mg flac

7640369610460 CH-68734 L04AB02

Reimbursement limitations:

REMSIMA4

Substitution préparation de référence/biosimilaire
Le traitement par REMSIMA exige une garantie préalable de prise en …

REMSIMA (IP-APS) subst sèche 100 mg flac
REMSIMA (IP-APS) subst sèche 100 mg flac
REMSIMA (IP-APS) subst sèche 100 mg flac
1 / 3
google

Details

Product number
-
CPT
-
Packaging group
-
Unit
-

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
12/08/2024
Professional SmPC
Français
12/08/2024
Professional SmPC
Italien
12/08/2024

Detailed composition

Substance Quantity Type Category
PRC
100.0 MG Substance Wirkstoff (Principe actif)

Reimbursement information

Public price
CHF 510.10
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/05/2023

Authorization holder

APS-Arzneimittel-Parallelimport-

6330 Cham

Authorization information

Swissmedic authorization number
68734
Drug name
Remsima, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Galenic form
PULPI
ATC Code
L04AB02
Authorization status
Z
Authorization category
Category P
Dispensation category
A
First authorization
16/06/2022
Authorization expiration date
15/06/2027
IT number
07.15.0.
Domain
Human medicine
Field of application
Rheumatoide Arthritis; Psoriatische Arthritis; Morbus Crohn; Morbus Bechterew; aktive ulcerative Colitis; Plaque-Psoriasis

Packaging details

Description (FR)
REMSIMA (IP-APS) subst sèche 100 mg flac
Description (DE)
REMSIMA (PI-APS) Trockensub 100 mg Durchstf
Market launch
16/06/2022
Narcotic (BTM)
No